Identification of biomarkers for diagnosis of major depression

Identification of biomarkers for diagnosis of major depression - Identification of biomarkers of depression

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000025307

Enrollment

Registered

2017-01-01

Start date

2017-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major depressive disorder

Interventions

Eight weeks of exercise therapy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Major depression group: Adults diagnosed as major depressive disorder Control group: Adults not diagnosed as major depressive disorder

Exclusion criteria

Exclusion criteria: 1. Suffers from any inflammatory, endocrine, or metabolic disorders or suffers from severe periodontal disease. 2. Has taken anti-allergic medication, steroid, or immunosuppressant medication in the past month. 3. Suffers from organic brain disease.

Design outcomes

Primary

Measure	Time frame
Hamilton depression rating scale, Montgomery-Asberg Depression Rating Scale, and salivary levels of cortisol, alpha-amylase, and cytokines.	—

Countries

Japan

Contacts

Public ContactDaimei Sasayama

Shinshu University School of Medicine Department of Psychiatry

sasayama@shinshu-u.ac.jp0263372638

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026